Ciencias de la vida y de la materia Microbiología: transmisión

Trasplante fecal: cuando la transmisión resulta saludable. El caso de la infección por Clostridium difficile

08/05/2015

Professor Mark Wilcox is a Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals (LTHT), Professor of Medical Microbiology at the University of Leeds (Leeds Institute of Molecular Medicine), and is the Lead on Clostridium difficile for the Public Health England (PHE). He has formerly been the Director of Infection Prevention (4 years), Infection Control Doctor (8 years) and Clinical Director of Pathology (6 years) at LTHT. Professor Wilcox is deputy Chair of the UK Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee and is a member of the HPA’s Programme Board on Healthcare Associated Infection and Antimicrobial Resistance. He is an advisor to the Department of Health in England on healthcare associated infections (HCAIs), the Technology Strategy Board on HCAI diagnostics, the UK EPIC/NICE projects, the Health Technology Assessment (HTA) programme on Healthcare Associated Infection, the Wellcome Trust on novel antimicrobials, and the European Centre for Disease Control. He is a member of UK, European and US working groups on C. difficile infection, and is on the Editorial Boards of the Journal of Hospital infection and Infectious Diseases in Clinical Practice. He has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents. Professor Wilcox’s research team’s projects include several areas of healthcare associated infection, in particular Clostridium difficile infection, staphylococcal infection, and the clinical development of new antimicrobial agents. He has a track record of translational research, including providing the basis of clinical advice to the NHS. He has been the Principal/UK Investigator for 12 clinical trials of new anti-infective drugs, 1999-2010, is currently supplying central laboratory services for 4 clinical trials of antimicrobial agents, and is carrying out multiple NIHR portfolio studies on healthcare associated infection topics. He has authored more than 320 papers and published a number of books and chapters. He is co-editor of Antimicrobial Chemotherapy (5th and 6th Eds, 2007 and 2012).

"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Vídeos
Ciencias de la vida y de la materia Microbiología: transmisión

Transmisión, población humana y patogenicidad: el caso del ÉBOLA I

07/05/2015

Transmisión, población humana y patogenicidad: el caso del ÉBOLA II

07/05/2015

La vacunación contra dianas móviles para detener la transmisión: el ejemplo de la vacunación estacional frente al virus de la gripe

07/05/2015

Transmisión, introgresión y evolución

07/05/2015

Transmisión genética de bacteria a bacteria

Procesos básicos en las interacciones bacteria-huésped: entre la evolución del huésped y la transmisión del genotipo virulento

07/05/2015

Transmisión desde los huéspedes al medio ambiente

07/05/2015

Ecología y evolución de la transferencia génica cromosomal entre microorganismos ambientales y patógenos

07/05/2015

Epidemiología experimental de la resistencia antibiótica: en busca de un sistema de modelo animal adecuado

07/05/2015

Transmisión bacteriana del animal al humano

07/05/2015

Transmisión bacteriana de los alimentos a los humanos

07/05/2015

Transmisión desde los abonos y efluentes de fosas sépticas al suelo y las plantas

07/05/2015

Evolución de las estrategias de genotipado para la detección, análisis y control de la tuberculosis

08/05/2015

Transmission in hospitals: nosocomial infections

08/05/2015

El medio ambiente como vehículo para la transmisión de las enfermedades fúngicas en los hospitales: los modelos Aspergillus y Candida

08/05/2015

Trasplante fecal: cuando la transmisión resulta saludable. El caso de la infección por Clostridium difficile

08/05/2015